Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant

Vaccine

Volumn 16, Issue 1, 1998, Pages 33-37

  Marchetti, Marta ^a   Rossi, Michela ^a   Giannelli, Valentina ^a   Giuliani, Marzia M ^a   Pizza, Mariagrazia ^a   Censini, Stefano ^a   Covacci, Antonello ^a   Massari, Paola ^a   Pagliaccia, Cristina ^a   Manetti, Roberto ^a   Telford, John L ^a   Douce, Gill ^b   Dougan, Gordon ^b   Rappuoli, Rino ^a   Ghiara, Paolo ^a  

^a CHIRON VACCINES   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

H. pylori mouse model; H. pylori vaccine; Non toxic LT mutants

Indexed keywords

BACTERIAL VACCINE; ESCHERICHIA COLI ENTEROTOXIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GASTRITIS; HELICOBACTER PYLORI; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BACTERIAL VACCINES; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; MICE; VACCINES, SYNTHETIC;

EID: 0031986493     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00153-9     Document Type: Article

References (22)

1. Blaser M.J., Parsonnet J. Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest. 94:1994;4-8.
2. Telford J.L., Covacci A., Ghiara P., Montecucco C., Rappuoli R. Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential for new therapies and vaccines. Trends Biotechnol. 12:1994;420-426.
3. Marchetti M., Arico B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 267:1995;1655-1658.
4. Chen M., Lee A., Hazell S. Immunisation against gastric Helicobacter infection in a mouse/Helicobacter felis model. Lancet. 339:1992;1120-1121.
5. Ferrero R.L., Thiberge J.M., Huerre M., Labigne A. Recombinant antigens prepared from the urease subunits of Helicobacter spp: evidence of protection in a mouse model of gastric infection. Infect. Immun. 62:1994;4981-4989.
6. Michetti P., Corthésy-Theulaz I., Davin C., Haas R., Vaney A.C., Heitz M., Bille J., Kraehenbuhl J.P., Saraga E., Blum A.L. Immunization of BALB/c mice against Helicobacter felis infection with H. pylori urease. Gastroenterology. 107:1994;1002-1011.
7. Lee A., Chen M.H. Successful immunization against gastric infection with Helicobacter species: Use of a cholera toxin B-subunit- whole-cell vaccine. Infect. Immun. 62:1994;3594-3597.
8. Nedrud J., Blanchard T., Czinn S., Lycke N. Recombinant cholera toxin B subunit is not an adjuvant for oral immunization against Helicobacter felis in mice. J. Cell. Biochem. Abstract suppl 19A:1995;261.
9. Pizza M., Fontana M.R., Giuliani M.M., Domenighini M., Magagnoli C., Gianelli V., Nucci D., Hol W., Manetti R., Rappuoli R. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med. 80:1994;2147-2153.
10. Douce G., Trucotte C., Cropley I., Roberts M., Pizza M., Domenighini M., Rappuoli R., Dougan G. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltrasferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA. 92:1995;1644-1648.
11. Giannelli V., Fontana M.R., Giuliani M.M., Guancai D., Rappuoli R., Pizza M. Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop. Infect. Immun. 65:1997;331-334.
12. Di Tommaso A., Saletti G., Pizza M., Rappuoli R., Dougan G., Abrignani S., Douce G., De Magistris M.T. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:1996;974-979.
13. Partidos C.D., Pizza M., Rappuoli R., Steward M.W. The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of virus-specific CTL responses after intranasal co-immunization with a synthetic peptide. Immunology. 89:1996;483-487.
14. Telford J.L., Ghiara P., Dellorco M., Comanducci M., Burroni D., Bugnoli M., Tecce M.F., Censini S., Covacci A., Xiang Z.Y., Papini E., Montecucco C., Parente L., Rappuoli R. Gene Structure of the Helicobacter pylori Cytotoxin and Evidence of Its Key Role in Gastric Disease. J. Exp. Med. 179:1994;1653-1658.
15. Manetti R., Massari P., Burroni D., De Bernard M., Marchini A., Olivieri R., Papini E., Montecucco C., Rappuoli R., Telford J.L. Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect. Immun. 63:1995;4476-4480.
16. Xiang Z., Bugnoli M., Ponzetto A., Morgando A., Figura N., Covacci A., Petracca R., Pennatini C., Censini S., Armellini D., Rappuoli R. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 12:1993;739-745.
17. Covacci A., Censini S., Bugnoli M., Petracca R., Burroni D., Macchia G., Massone A., Papini E., Xiang Z., Figura N., Rappuoli R. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA. 90:1993;5791-5795.
18. Xiang Z., Censini S., Bayeli P.F., Telford J.L., Figura N., Rappuoli R., Covacci A. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63:1995;94-98.
19. McColm A.A., Bagshaw J., Wallis J., McLaren A. Screening of anti-Helicobacter therapies in mice colonized with H. pylori. Gut. 37 (Suppl. 1):1995;A92.
20. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 12:1994;387-400.
21. Censini S., Lange C., Xiang Z.Y., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA. 93:1996;14648-14653.
22. Ghiara P., Marchetti M., Blaser M.J., Tummuru M.K.R., Cover T.L., Segal E.D., Tompkins L.S., Rappuoli R. Role of the Helicobacter pylori virulence factors Vacuolating Cytotoxin, CagA and Urease in a mouse model of disease. Infect. Immun. 63:1995;4154-4160.